- Home
- ATNF vs PTIX Comparison
ATNF vs PTIX Comparison
Compare ATNF & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- PTIX
- Stock Information
- Founded
- ATNF 2016
- PTIX 1994
- Country
- ATNF United States
- PTIX United States
- Employees
- ATNF N/A
- PTIX N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- ATNF Health Care
- PTIX Health Care
- Exchange
- ATNF Nasdaq
- PTIX Nasdaq
- Market Cap
- ATNF 3.8M
- PTIX 3.3M
- IPO Year
- ATNF N/A
- PTIX 2016
- Fundamental
- Price
- ATNF $0.83
- PTIX $3.83
- Analyst Decision
- ATNF
- PTIX
- Analyst Count
- ATNF 0
- PTIX 0
- Target Price
- ATNF N/A
- PTIX N/A
- AVG Volume (30 Days)
- ATNF 35.4K
- PTIX 210.6K
- Earning Date
- ATNF 08-11-2025
- PTIX 08-13-2025
- Dividend Yield
- ATNF N/A
- PTIX N/A
- EPS Growth
- ATNF N/A
- PTIX N/A
- EPS
- ATNF N/A
- PTIX N/A
- Revenue
- ATNF N/A
- PTIX N/A
- Revenue This Year
- ATNF N/A
- PTIX N/A
- Revenue Next Year
- ATNF N/A
- PTIX N/A
- P/E Ratio
- ATNF N/A
- PTIX N/A
- Revenue Growth
- ATNF N/A
- PTIX N/A
- 52 Week Low
- ATNF $0.66
- PTIX $2.35
- 52 Week High
- ATNF $17.75
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- ATNF 35.60
- PTIX 53.21
- Support Level
- ATNF $0.95
- PTIX $3.55
- Resistance Level
- ATNF $1.04
- PTIX $3.97
- Average True Range (ATR)
- ATNF 0.08
- PTIX 0.23
- MACD
- ATNF -0.01
- PTIX 0.04
- Stochastic Oscillator
- ATNF 17.41
- PTIX 81.83
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.